HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
Medigene AG
Medigene AG
Rutgers, The State University of New Jersey
Bellicum Pharmaceuticals
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Rutgers, The State University of New Jersey
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco